Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Vir Biotechnology Inc VIR

Healthcare Biotechnology
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company’s preclinical candidates include those... see more

Current News (NDAQ:VIR)

Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones

Business Wire 7 days ago

Vir Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Business Wire January 5, 2026

Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing Agreement for Ongoing ECLIPSE Clinical Development Program

Business Wire December 16, 2025

Vir Biotechnology to Participate in the 8th Annual Evercore Healthcare Conference

Business Wire November 19, 2025

Vir Biotechnology Announces AASLD The Liver Meeting® Presentation & New England Journal of Medicine Publication of Phase 2 Data Demonstrating Tobevibart & Elebsiran Combination Deliver High Rates of Undetectable HDV RNA with Favorable Safety Profile

Business Wire November 9, 2025

Vir Biotechnology to Participate in the Jefferies 2025 London Healthcare Conference

Business Wire November 7, 2025

Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2025 Financial Results

Business Wire November 5, 2025

Vir Biotechnology Announces Completion of Enrollment in ECLIPSE 1 Phase 3 Trial for Chronic Hepatitis Delta

Business Wire November 3, 2025

Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2025 Financial Results on November 5, 2025

Business Wire October 22, 2025
View More News ››

Opinion & Analysis (NDAQ:VIR)

Vir Partners with Samsung Biologics on Large-Scale Manufacture of COVID-19 Antibody Treatment

Streetwise Reports April 13, 2020

Vir Biotech Shares Rise on Joint Research Efforts with the NIH to Combat Coronaviruses

Streetwise Reports March 12, 2020
View More Opinion ››

Bullboard Posts (NDAQ:VIR)

Using technical analysis for this stock.

It is looking really good here for this company today and it's starting to climb up from its low stock price.
coolfooldumbguy - January 8, 2025

RE:The only pill against Omicron?

Oops: The name of the pill is "Sotromivab". It is commercialized by GSK "GlaxoSmithKline"
emiltech - January 11, 2022

The only pill against Omicron?

Looks like it is in a sweet spot. Available only for immuno-depressed patients for now. Hope it could be available to the general cohorts...
emiltech - January 11, 2022

$iMIN making moves in Ethereum Crypto !! 🚀🚀🚀🚀🚀

iMining Launches Fractional Staking to Enable Retail Investors to Participate in Ethereum 2.0's Proof-Of-Stake Mining Vancouver...
Saaaa1 - May 6, 2021
View more Bullboard ››

Globex Mining Enterprises Inc.

Globex Mining Enterprises Inc.

Globex Mining Enterprises Inc. engages in the acquisition, exploration, and development of mineral properties in North ...
View More »

Podcasts